The effect of fluoroquinolones on the acid-fast bacillus smear and culture of patients with pulmonary tuberculosis

Clinical Pulmonary Medicine

Volumn 13, Issue 3, 2006, Pages 164-168

  Sierros, Vasilios ^a,b   Khan, Raymond ^a   Hans, Joo Lee ^a   Sabaye, Vladimir ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

AFB; Culture; Fluoroquinolones; Smear; Tuberculosis

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACID FAST BACTERIUM; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CLINICAL ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DELAYED DIAGNOSIS; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; LUNG LAVAGE; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; SHORT COURSE THERAPY; SMEAR; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULIN TEST;

EID: 33646786791     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000218459.07407.1d     Document Type: Article

References (13)

1. Alangaden GJ, Lerner SA. The clinical use of fluoroquinolones for the treatment of mycobacterial diseases. Clin Infect Dis. 1997;25:1213-1221.
2. Jacobs MR. Activity of quinolones against mycobacteria. Drugs. 1999;58(suppl 2):19-22.
3. Agarwal A, Agarwal V. Inadvertent use of ciprofloxacin as a single drug in undiagnosed tuberculosis. J Assoc Physicians India. 1997;45:747.
4. Deleted in proof.
5. Pletz MW, De Roux A, Roth A, et al. Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study. Antimicrob Agents Chemother. 2004;48:780-782.
6. Kennedy N, Fox R, Kisyombe G, et al. Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis. Am Rev Respir Dis. 1993;148:1547-1551.
7. Sirgel FA, Botha FJ, Parkin DP, et al. The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis. Am J Respir Crit Care Med. 1997;156:901-905.
8. Dooley KE, Golub J, Goes FS, et al. Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis. Clin Infect Dis. 2002;34:1607-1612.
9. Tomioka H, Sato K, Shimizu T, et al. Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs. J Infect. 2002;44:160-165.
10. http://www.paho.org/English/AD/DPC/CD/tb-fact-sheet-2004.pdf.
11. Prabhakaran K, Harris EB, Randhawa B. Suppression of the growth of six potentially-pathogenic mycobacteria by beta-lactam/beta-lactamase-inhibitors. Microbios. 1997;91:7-14.
12. Watt B, Rayner A, Harris G. Comparative activity of azithromycin against clinical isolates of mycobacteria. J Antimicrob Chemother. 1996;38:539-542.
13. Yew WW, Piddock LJ, Li MS, et al. In-vitro activity of quinolones and macrolides against mycobacteria. J Antimicrob Chemother. 1994;34:343-351.